Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
Over the last 12 months, insiders at Biodesix, Inc. have bought $821,546 and sold $220,281 worth of Biodesix, Inc. stock.
On average, over the past 5 years, insiders at Biodesix, Inc. have bought $28.65M and sold $198,219 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SCHULER JACK W () — $2.96M. Strobeck Matthew (director) — $223,664. PATIENCE JOHN (Chairman) — $207,420.
The last purchase of 100,000 shares for transaction amount of $122,840 was made by SCHULER JACK W () on 2024‑11‑21.
2024-11-21 | 100,000 0.0687% | $1.23 | $122,840 | +12.92% | ||||
2024-11-21 | 35,000 0.0227% | $1.16 | $40,562 | +12.92% | ||||
2024-11-20 | 200,000 0.1375% | $1.17 | $234,000 | +13.45% | ||||
2024-11-12 | Sale | President & CEO | 1,813 0.0013% | $1.40 | $2,540 | -3.57% | ||
2024-11-12 | Sale | CFO, Sec'y & Treasurer | 471 0.0003% | $1.40 | $660 | -3.57% | ||
2024-11-12 | Sale | Chief Development Officer | 207 0.0001% | $1.40 | $290 | -3.57% | ||
2024-11-12 | Sale | Chief Commercial Officer | 224 0.0002% | $1.40 | $314 | -3.57% | ||
2024-11-12 | Sale | Chief Accounting Officer | 98 <0.0001% | $1.40 | $137 | -3.57% | ||
2024-11-11 | Sale | President & CEO | 1,927 0.0013% | $1.39 | $2,680 | -4.26% | ||
2024-11-11 | Sale | CFO, Sec'y & Treasurer | 500 0.0003% | $1.39 | $695 | -4.26% | ||
2024-11-11 | Sale | Chief Development Officer | 220 0.0001% | $1.39 | $306 | -4.26% | ||
2024-11-11 | Sale | Chief Commercial Officer | 238 0.0002% | $1.39 | $331 | -4.26% | ||
2024-11-11 | Sale | Chief Accounting Officer | 105 <0.0001% | $1.39 | $146 | -4.26% | ||
2024-11-06 | 20,000 0.0139% | $1.36 | $27,180 | +1.88% | ||||
2024-11-05 | 100,253 0.0679% | $1.36 | $136,585 | -0.91% | ||||
2024-11-05 | 51,200 0.0348% | $1.36 | $69,888 | -1.10% | ||||
2024-11-05 | director | 40,000 0.0278% | $1.40 | $55,916 | -3.43% | |||
2024-11-05 | Chairman | 75,000 0.0516% | $1.38 | $103,710 | -2.37% | |||
2024-11-05 | director | 22,500 0.0154% | $1.37 | $30,866 | -1.59% | |||
2024-08-12 | Sale | President & CEO | 963 0.0007% | $1.57 | $1,514 | +4.97% |
SCHULER JACK W | 31194935 21.4447% | $1.30 | 31 | 0 | <0.0001% | |
Kennedy Lawrence T. Jr | 10411024 7.157% | $1.30 | 5 | 0 | +22.69% | |
Strobeck Matthew | director | 2606879 1.7921% | $1.30 | 6 | 0 | +0.18% |
PATIENCE JOHN | Chairman | 2153298 1.4803% | $1.30 | 10 | 0 | <0.0001% |
Hutton Scott | President & CEO | 532979 0.3664% | $1.30 | 2 | 20 | <0.0001% |
Cowie Robin Harper | CFO, Sec'y & Treasurer | 203336 0.1398% | $1.30 | 2 | 20 | <0.0001% |
Pestano Gary Anthony | Chief Development Officer | 127027 0.0873% | $1.30 | 0 | 20 | |
O'Kane Kieran | Chief Commercial Officer | 97448 0.067% | $1.30 | 0 | 20 | |
MASSARANY HANY | director | 53364 0.0367% | $1.30 | 4 | 0 | +21.75% |
Vazquez Chris | Chief Accounting Officer | 11587 0.008% | $1.30 | 0 | 11 | |
Kayyem Jon Faiz | director | 173913 0.1196% | $1.30 | 2 | 0 | +22.69% |
Watts Charles M | director | 51333 0.0353% | $1.30 | 4 | 0 | +1.45% |
Siurek Ryan H | Chief Accounting Officer | 40268 0.0277% | $1.30 | 0 | 9 | |
Georgantas Robert William III | Chief Scientific Officer | 26114 0.018% | $1.30 | 1 | 6 | +19.87% |
Birchview Capital Lp | $7.42M | 4.53 | 5.19M | 0% | +$0 | 0.41 | |
Aigh Capital Management Llc | $4.75M | 2.9 | 3.32M | -28.72% | -$1.91M | 2.72 | |
Telemark Asset Management LLC | $1.9M | 1.16 | 1.33M | +1,644.74% | +$1.79M | 0.21 | |
ESSEX INVESTMENT MANAGEMENT CO LLC | $1.32M | 0.81 | 925,614 | +1.39% | +$18,116.67 | 0.27 | |
Wells Fargo | $1.28M | 0.78 | 893,203 | +1.08% | +$13,656.51 | <0.0001 | |
The Vanguard Group | $1.16M | 0.7 | 807,928 | -0.47% | -$5,466.89 | <0.0001 | |
Opaleye Management Inc | $764,560.00 | 0.47 | 534,657 | +7.68% | +$54,564.54 | 0.17 | |
BlackRock | $576,158.00 | 0.35 | 402,908 | -0.38% | -$2,220.79 | <0.0001 | |
Geode Capital Management | $550,853.00 | 0.34 | 385,145 | +7.85% | +$40,085.57 | <0.0001 | |
Legato Capital Management Llc | $478,063.00 | 0.29 | 334,310 | 0% | +$0 | 0.06 | |
State Street | $393,751.00 | 0.24 | 275,350 | 0% | +$0 | <0.0001 | |
Bridgeway Capital Management | $328,418.00 | 0.2 | 229,663 | +0.2% | +$662.09 | 0.01 | |
Spears Abacus Advisors LLC | $294,015.00 | 0.18 | 205,605 | New | +$294,015.00 | 0.01 | |
Susquehanna International Group | $272,238.00 | 0.17 | 190,376 | +1,109.58% | +$249,731.20 | <0.0001 | |
Hightower Advisors | $188,000.00 | 0.12 | 131,434 | 0% | +$0 | <0.0001 | |
Millennium Management LLC | $144,080.00 | 0.09 | 100,755 | +10.33% | +$13,492.08 | <0.0001 | |
Allworth Financial Lp | $142,044.00 | 0.09 | 99,331 | +77.84% | +$62,173.83 | <0.01 | |
Jane Street Capital | $132,825.00 | 0.08 | 92,885 | +112.06% | +$70,189.83 | <0.0001 | |
Blair William Co Il | $114,114.00 | 0.07 | 79,800 | -11.14% | -$14,300.00 | <0.0001 | |
Cetera Advisor Networks LLC | $111,540.00 | 0.07 | 78,000 | 0% | +$0 | <0.01 | |
CETERA INVESTMENT ADVISERS LLC | $111,540.00 | 0.07 | 78,000 | New | +$111,540.00 | <0.0001 | |
Citigroup | $101,939.00 | 0.06 | 71,286 | +67.23% | +$40,982.38 | <0.0001 | |
Qube Research & Technologies | $99,381.00 | 0.06 | 69,497 | +5.93% | +$5,559.86 | <0.0001 | |
Northern Trust | $46,911.00 | 0.03 | 32,805 | +5.44% | +$2,419.55 | <0.0001 | |
Oracle Investment Management Inc | $43,402.00 | 0.03 | 30,351 | -50.19% | -$43,740.91 | 0.01 | |
Goldman Sachs | $39,379.00 | 0.02 | 27,538 | New | +$39,379.00 | <0.0001 | |
Charles Schwab | $29,489.00 | 0.02 | 20,622 | 0% | +$0 | <0.0001 | |
Ci Private Wealth Llc | $22,161.00 | 0.01 | 15,497 | 0% | +$0 | <0.0001 | |
Squarepoint Ops LLC | $19,511.00 | 0.01 | 13,644 | New | +$19,511.00 | <0.0001 | |
Renaissance Technologies | $19,000.00 | 0.01 | 13,200 | -72.95% | -$51,242.42 | <0.0001 | |
Cibc Private Wealth Group Llc | $19,257.00 | 0.01 | 13,100 | 0% | +$0 | <0.0001 | |
Jefferies Financial Group | $16,302.00 | 0.01 | 11,400 | New | +$16,302.00 | <0.0001 | |
OMERS | $16,046.00 | 0.01 | 11,221 | New | +$16,046.00 | <0.0001 | |
NWAM, LLC | $15,500.00 | 0.01 | 10,000 | New | +$15,500.00 | <0.01 | |
Brevan Howard Capital Management Lp | $15,051.00 | 0.01 | 10,525 | New | +$15,051.00 | <0.01 | |
Barclays | $13,000.00 | 0.01 | 9,291 | 0% | +$0 | <0.0001 | |
Morgan Stanley | $13,118.00 | 0.01 | 9,173 | -9.49% | -$1,375.72 | <0.0001 | |
Tower Research Capital | $11,051.00 | 0.01 | 7,728 | -12.52% | -$1,581.57 | <0.0001 | |
Bank of America | $6,700.00 | <0.01 | 4,685 | -56.26% | -$8,617.76 | <0.0001 | |
Simplex Trading Llc | $1,000.00 | <0.01 | 1,071 | New | +$1,000.00 | <0.0001 | |
Macquarie Group | $1,000.00 | <0.01 | 512 | New | +$1,000.00 | <0.0001 |